Detalhe da pesquisa
1.
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset.
Ann Neurol
; 95(5): 951-965, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400792
2.
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease.
Alzheimers Dement
; 15(5): 655-665, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846386
3.
Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.
Clin Chem
; 64(6): 927-937, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29523639
4.
Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease.
Alzheimers Dement
; 14(7): 869-879, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29580670
5.
Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid.
Ann Neurol
; 80(1): 154-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27129429
6.
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease.
Brain Commun
; 6(2): fcae081, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38505230
7.
Double Monoclonal Immunoassay for Quantifying Human Visinin-Like Protein-1 in CSF.
Clin Chem
; 63(2): 603-604, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27986783
8.
Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
Neurology
; 96(20): e2546-e2557, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33795390
9.
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
Alzheimers Res Ther
; 7(1): 59, 2015 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26383836
10.
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.
JAMA Neurol
; 72(11): 1275-80, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26366630